+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Felodipine"

Calcium Channel Blocker Market Report 2025 - Product Thumbnail Image

Calcium Channel Blocker Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Calcium Channel Blockers - Global Strategic Business Report - Product Thumbnail Image

Calcium Channel Blockers - Global Strategic Business Report

  • Report
  • August 2025
  • 93 Pages
  • Global
From
Hypertension Drugs Markets in China - Product Thumbnail Image

Hypertension Drugs Markets in China

  • Report
  • March 2025
  • 215 Pages
  • China
From
Hypertension Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Hypertension Drugs Industry Forecasts - China Focus

  • Report
  • March 2025
  • 109 Pages
  • China
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Felodipine is a calcium channel blocker used to treat hypertension and angina pectoris. It is a member of the dihydropyridine class of calcium channel blockers, which are the most commonly prescribed drugs for the treatment of hypertension. Felodipine works by blocking the influx of calcium ions into the smooth muscle cells of the heart and blood vessels, resulting in a decrease in blood pressure. It is also used to treat congestive heart failure and to reduce the risk of stroke and heart attack. Felodipine is available in both immediate-release and extended-release formulations. The extended-release formulation is designed to provide a more consistent blood pressure-lowering effect throughout the day. Common side effects of felodipine include headache, dizziness, nausea, and swelling of the ankles and feet. The cardiovascular drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the felodipine market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more